SSG Capital Advisors, LLC (“SSG”) served as the investment banker to Blue Spark Technologies, Inc. (“Blue Spark” or the “Company”) in the sale of substantially all assets to BST Technology Acquisition, Inc. The transaction closed in March 2025.
Blue Spark Technologies is a medical technology company focused on developing innovative, wearable vital sign monitoring devices. The Company’s flagship product, TempTraq®, is a wireless continuous temperature monitoring single-use patch that transmits real-time and historical data, via Bluetooth, for up to 72 hours. TempTraq® is FDA and CE cleared and was internally developed using the Company’s proprietary technology surrounding flexible, thin-printed batteries and biosensors.
From its inception in 2002, Blue Spark has been innovating continuous vital sign monitoring solutions that improve patient care and outcomes. The Company’s extensive research, product development, and testing efforts shifted toward commercialization, which required a financial partner to support the sales cycle and increase wider adoption.
SSG was retained in October 2024 to explore strategic alternatives, including new investment or a sale of the Company. SSG’s comprehensive marketing process attracted significant interest from both strategic and financial investors. BST Technology Acquisition, Inc. provided the best option to partner with Blue Spark and maximize value for all stakeholders.
BST Technology Acquisition, Inc. is a medical technology holding company established by representatives of SunBridge Partners, specifically to acquire the assets of Blue Spark. SunBridge Partners is a venture capital firm founded in 2004 as part of Japan-based SunBridge, specializing in cofounding and scaling Japan subsidiaries of global tech companies and making early-stage investments in the U.S. and Japan.
